title: Introduction. Herceptin: HER2 status--changing clinical practice.
authors.affiliation: Institut Jules Bordet, Unite de Chimiotherapie, 1 Rue Héger-Bordet, B-1000 Brussels, Belgium. mpiccart@ulb.ac.be
authors.forename: M
authors.initials: M
authors.lastname: Piccart
authors.forename: M
authors.initials: M
authors.lastname: Kaufmann
mesh_terms: D000911:Antibodies, Monoclonal / Q000627:therapeutic use*; D061067:Antibodies, Monoclonal, Humanized; D000970:Antineoplastic Agents / Q000627:therapeutic use*; D001943:Breast Neoplasms / Q000188:drug therapy* / Q000378:metabolism; D005260:Female; D006801:Humans; D018719:Erb-b2 Receptor Tyrosine Kinases / Q000378:metabolism*; D000068878:Trastuzumab
chemical_list: D000911:Antibodies, Monoclonal; D061067:Antibodies, Monoclonal, Humanized; D000970:Antineoplastic Agents; D018719:Erb-b2 Receptor Tyrosine Kinases; D000068878:Trastuzumab